Literature DB >> 11333376

Congenital toxoplasmosis: a review.

J L Jones1, A Lopez, M Wilson, J Schulkin, R Gibbs.   

Abstract

Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii. In the United States, approximately 85% of women of childbearing age are susceptible to acute infection with T. gondii. Acute infections in pregnant women may cause serious health problems when the organism is transmitted to the fetus (congenital toxoplasmosis), including mental retardation, seizures, blindness, and death. An estimated 400 to 4000 cases of congenital toxoplasmosis occur in the U.S. each year. Manifestations of congenital toxoplasmosis may not become apparent until the second or third decade of life. Serologic tests are used to diagnose acute infection in pregnant women, but false-positive tests occur frequently, therefore, serologic diagnosis must be confirmed at a reference laboratory before treatment with potentially toxic drugs should be considered. Much of congenital toxoplasmosis can be prevented by educating women of childbearing age and pregnant women to avoid eating raw or undercooked meat, to avoid cross-contamination of other foods with raw or undercooked meat, and to use proper cat-litter and soil-related hygiene.

Entities:  

Mesh:

Year:  2001        PMID: 11333376     DOI: 10.1097/00006254-200105000-00025

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  61 in total

1.  Seroprevalence and incidence of Toxoplasma gondii among apparently healthy and visually or hearing disabled children in Taiz City, Yemen.

Authors:  Madha Mohammed Sheet Saleh; Adam Hezam AL-Shamiri; Abeer Ahmed Qaed
Journal:  Korean J Parasitol       Date:  2010-03-18       Impact factor: 1.341

2.  Chemistry and biology of macrolide antiparasitic agents.

Authors:  Younjoo Lee; Jun Yong Choi; Hong Fu; Colin Harvey; Sandeep Ravindran; William R Roush; John C Boothroyd; Chaitan Khosla
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

3.  Surface properties of Toxoplasma gondii oocysts and surrogate microspheres.

Authors:  Karen Shapiro; John Largier; Jonna A K Mazet; William Bernt; John R Ell; Ann C Melli; Patricia A Conrad
Journal:  Appl Environ Microbiol       Date:  2008-12-05       Impact factor: 4.792

4.  Towards Universal Screening for Toxoplasmosis: Rapid, Cost-Effective, and Simultaneous Detection of Anti-Toxoplasma IgG, IgM, and IgA Antibodies by Use of Very Small Serum Volumes.

Authors:  Swinburne A J Augustine
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

5.  Prenatal toxoplasmosis antibody and childhood autism.

Authors:  Marisa N Spann; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Alan S Brown
Journal:  Autism Res       Date:  2016-11-22       Impact factor: 5.216

6.  Fetomaternal and Pediatric Toxoplasmosis.

Authors:  Helieh S Oz
Journal:  J Pediatr Infect Dis       Date:  2017-12       Impact factor: 0.293

7.  Congenital Toxoplasmosis.

Authors:  James B McAuley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

8.  Human trophoblast responses to Porphyromonas gingivalis infection.

Authors:  S D Riewe; J J Mans; T Hirano; J Katz; K T Shiverick; T A Brown; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

9.  Listeriosis in the pregnant guinea pig: a model of vertical transmission.

Authors:  Anna I Bakardjiev; Brian A Stacy; Susan J Fisher; Daniel A Portnoy
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 10.  Infection and stillbirth.

Authors:  Elizabeth M McClure; Robert L Goldenberg
Journal:  Semin Fetal Neonatal Med       Date:  2009-03-12       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.